Episode 64: Ethical Dilemmas of COVID-19 With Alison Bateman-House
Alison Bateman-House returns to discuss the ethics of “expanded access” and “Right To Try” when treating COVID-19.
Alison Bateman-House returns to discuss the ethics of “expanded access” and “Right To Try” when treating COVID-19.
Nurses join Chadi to discuss COVID-19 at their institutions.
Emily Landon, MD returns for her fourth update on COVID-19
Niesha Griffith and Michael Ganio provide varying perspectives on the potential of drug shortages (eg, pain medications, cancer therapies, and hydroxychloroquine) emerging during the COVID-19 pandemic, as well as how the supply chain functions through the ASHP when a shortage is identified.
Cam Harvey, PhD, professor of finance, Duke University, shares how his June 2019 prediction of a recession in 2020 is being further fueled by COVID-19, compares the pandemic to the likes of the Spanish Flu and SARS in terms of “systemic risk,” breaks down the finances of the recently enacted CARES Act, floats the idea of a federal strategic medical equipment reserve, and more.
Emily Landon, MD returns to share valuable information on COVID-19 testing, ethical dilemmas regarding treatment decisions, proper N95 mask reuse and disposal, the potential of durable immunity to the virus, and more.
Stefano Luminari, MD, associate professor of oncology, University of Modena (Italy), provides an update on the COVID-19 situation in Italy, including operational measures undertaken when there was an increase in demand for ICU hospital beds, the country’s underestimation of the seriousness of the disease at the beginning of the outbreak, how hospital staff are protecting themselves from the virus, and more.
Priya Sampathkumar, MD, infectious disease specialist and hospital epidemiologist, Mayo Clinic, breaks down truths and misconceptions of which types of individuals should wear masks in public, proper gown and mask use for health care providers treating and not treating COVID-19, when N95 masks are truly needed and reasons for the potential shortage, and more in this provocative discussion.
the award-winning hematologist and a medical oncologist who hosted Outspoken Oncology, a podcast featuring candid discussions of the most pressing, and often controversial, medical topics. Combining his background in cancer research and health care advocacy, Dr. Nabhan brings a unique and powerful perspective to current medical events.
Chadi Nabhan, MD, MBA, brings a unique and powerful perspective to current medical events. Host of the award winning podcast Outspoken Oncology… Read More
Innovative Oncology Consulting offers insight, leadership and valuable assessment to health care systems through the county. They are recognized for… Read More